[시장보고서]세계의 말 헬스케어 시장 - 산업규모, 점유율, 동향, 기회, 예측, 제품별, 적응증별, 활동별, 유통채널별, 지역별 부문, 경쟁(2020-2030년)

세계의 말 헬스케어 시장 - 산업규모, 점유율, 동향, 기회, 예측, 제품별, 적응증별, 활동별, 유통채널별, 지역별 부문, 경쟁(2020-2030년)

Equine Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Activity, By Distribution Channel, By Region and Competition, 2020-2030F

상품코드 : 1691710

리서치사 : TechSci Research

발행일 : 2025년 03월

페이지 정보 : 영문 184 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,501,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,946,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,558,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

말 헬스케어 세계 시장 규모는 2024년에 35억 8,000만 달러였으며, 예측 기간에 57억 7,000만 달러에 달할 것으로 예상됩니다. 2030년까지 CAGR은 8.26%를 나타낼 것으로 예측됩니다.

세계 말 헬스케어 시장은 말의 건강 관리에 대한 의식 증가와 수의학적 케어에 대한 투자 증가로 꾸준한 성장을 이루고 있습니다. 마주, 브리더, 승무원이 동물 복지를 우선시하기 때문에 백신, 구충제 및 고급 진단 도구를 포함한 예방 건강 관리 솔루션에 대한 수요가 확대되고 있습니다. 실시간 건강 상태를 추적하기 위한 기술적으로 고급 모니터링 장비와 웨어러블 센서의 채용이 증가하고 있기 때문에 말 헬스케어의 실천이 변화하고 있습니다. 이 업계에서는 말에 특화된 보험도 급증하고 있으며, 고급 치료가 더욱 친숙해지고 있습니다. 말의 재활센터의 출현과 줄기 세포 치료 및 다혈소판 혈장 치료와 같은 재생 의료 치료는 시장 확대에 더욱 기여하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	35억 8,000만 달러
시장 규모 : 2030년	57억 7,000만 달러
CAGR : 2025-2030년	8.26%
급성장 부문	진단제
최대 시장	북미

시장은 말의 유형에 맞는 동물용 의약품, 영양제, 질병 관리 솔루션의 진보에 의해 견인되고 있습니다. 호흡기 질환, 말굽염, 감염을 포함한 말 질병의 확산이 확대되고 있으며 혁신적인 치료 옵션에 대한 수요가 증가하고 있습니다. 승마 스포츠 및 경주 참가자 증가는 성능 모니터링, 부상 예방, 정형외과적 치료의 필요성을 부추기고 있습니다. 원격 의료 및 AI 기반 진단 플랫폼과 같은 디지털 건강 솔루션의 채택은 수의학적 진찰과 치료 효율성을 향상시킵니다. 말의 질병 관리 및 바이오 보안 대책을 지원하는 정부의 이니셔티브도 시장 성장에 중요한 역할을합니다.

업계는 고도의 말 의료 치료와 관련된 고가의 비용과 원격지에서 전문적인 수의학에 대한 접근이 제한되어 있다는 과제에 직면하고 있습니다. 말용 의약품 승인에 대한 엄격한 규제와 동물 복지 정책은 새로운 건강 관리 제품의 상업화에 영향을 미칩니다. 동물용 의약품의 위조에 대한 우려와 진단 정밀도의 향상에 대한 요구가 더욱 장애물이 되고 있습니다. 말 집단에서 감염의 발생 관리는 여전히 중요한 문제이며 바이오 보안 대책과 예방 접종 프로그램의 강화가 필요합니다. 이 시장은 개별화된 말의 영양, 착용가능한 건강 모니터링 장비, 재생 치료에 있어서의 혁신의 기회를 제공하고 장기적인 성장을 가속할 것으로 기대됩니다.

주요 시장 성장 촉진요인

승마 스포츠 및 활동에 참가자 증가

주요 시장 과제

전문 의료에 드는 높은 비용

주요 시장 동향

정밀의료 및 맞춤형 의료

시장 규모와 예측
- 금액별
시장 점유율 및 예측
- 제품별(백신, 의약품, 의약 사료 첨가물, 진단, 소프트웨어 서비스, 기타)
- 적응증별(근골격 장애, 기생충 구제, 내과, 말 헤르페스 바이러스, 마뇌척수염, 말 인플루엔자, 웨스트 나일 바이러스, 파상풍, 기타)
- 액티비티별(스포츠, 레이스, 레크리에이션, 기타)
- 유통 채널별(동물 병원 및 클리닉, 전자상거래, 기타)
- 기업별(2024)
- 지역별
시장 맵

제6장 북미의 말 헬스케어 시장 전망

시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
- 멕시코
- 캐나다

제7장 유럽의 말 헬스케어 시장 전망

시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
- 독일
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 말 헬스케어 시장 전망

시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
- 인도
- 한국
- 일본
- 호주

제9장 남미의 말 헬스케어 시장 전망

시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카 말 헬스케어 시장 전망

시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트(UAE)

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

합병과 인수(해당하는 경우)
제품 발매(해당하는 경우)
최근 동향

제13장 Porter's Five Forces 분석

업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협

제14장 경쟁 구도

Zoetis Inc.
Boehringer Ingelheim GmbH
Merck & Co., Inc.
Hallmarq Veterinary Imaging Ltd
Esaote SpA
Vetoquinol SA
IDEXX Laboratories, Inc.
Dechra Pharmaceuticals PLC
Arthrex Inc.
Heska Corporation

제15장 전략적 제안

제16장 기업 소개와 면책사항

SHW

영문 목차

영문목차

Global Equine Healthcare Market was valued at USD 3.58 Billion in 2024 and is expected to reach USD 5.77 Billion in the forecast period with a CAGR of 8.26% through 2030. The Global Equine Healthcare Market is experiencing steady growth due to rising awareness about equine health management and increasing investments in veterinary care. The demand for preventive healthcare solutions, including vaccines, dewormers, and advanced diagnostic tools, is expanding as horse owners, breeders, and equestrian professionals prioritize animal welfare. The growing adoption of technologically advanced monitoring devices and wearable sensors for real-time health tracking has transformed equine healthcare practices. The industry is also witnessing a surge in specialized equine insurance policies, making advanced treatments more accessible. The emergence of equine rehabilitation centers and regenerative medicine therapies such as stem cell and platelet-rich plasma treatments is further contributing to market expansion.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.58 Billion
Market Size 2030	USD 5.77 Billion
CAGR 2025-2030	8.26%
Fastest Growing Segment	Diagnostics
Largest Market	North America

The market is driven by advancements in veterinary pharmaceuticals, nutrition, and disease management solutions tailored for equine species. The increasing prevalence of equine diseases, including respiratory disorders, laminitis, and infectious conditions, is pushing the demand for innovative treatment options. Rising participation in equestrian sports and racing is fueling the need for performance monitoring, injury prevention, and orthopedic care. The adoption of digital health solutions, such as telemedicine and AI-based diagnostic platforms, is enhancing veterinary consultations and treatment efficiency. Government initiatives supporting equine disease control and biosecurity measures are also playing a crucial role in market growth.

The industry faces challenges related to the high costs associated with advanced equine medical treatments and limited access to specialized veterinary care in remote areas. Stringent regulations governing equine drug approvals and animal welfare policies impact the commercialization of new healthcare products. Concerns over counterfeit veterinary drugs and the need for improved diagnostic accuracy pose additional hurdles. Managing infectious disease outbreaks in equine populations remains a critical issue, requiring enhanced biosecurity measures and vaccination programs. The market presents opportunities for innovation in personalized equine nutrition, wearable health monitoring devices, and regenerative therapies, which are expected to drive long-term growth.

Key Market Drivers

Rising Participation in Equestrian Sports and Activities

Equestrian sports and activities have a rich history that spans centuries, from the historic races of ancient Greece to the modern arenas of Olympic dressage. What was once a niche interest has now evolved into a global phenomenon, with millions of enthusiasts participating in various equestrian disciplines. This surge in equestrian engagement is not only shaping the sports landscape but also driving the growth of the global equine healthcare market.

As equestrian sports gain prominence, more people are investing in horse ownership. In the United States alone, the horse population was reported to be over 10.6 million in both 2020 and 2021, accounting for 18% of the world's equine population. Whether for competitive riding, leisure, or companionship, this rise in horse ownership creates a significant demand for equine healthcare services and products. Horse owners, recognizing the need to ensure the health and well-being of their equine partners, are fueling the growth of the equine healthcare market.

The growing equestrian community has fostered increased awareness of equine health and the importance of preventative measures. Horse owners, riders, and trainers understand that regular veterinary check-ups, vaccinations, and proper nutrition are essential to keeping their horses in peak condition. This heightened awareness drives the demand for equine healthcare solutions and encourages a proactive approach to horse care.

Key Market Challenges

High Cost of Specialized Care

The high cost of specialized care presents a significant challenge in the global equine healthcare market. Horses require extensive medical attention, including routine check-ups, vaccinations, dental care, and emergency treatments. When specialized care such as orthopedic surgeries, regenerative therapies, or advanced diagnostic imaging is needed, expenses rise considerably. Veterinary specialists trained in equine medicine often charge premium fees due to the complexity of procedures and the need for specialized equipment. Many horse owners struggle with these costs, especially those involved in non-commercial horse ownership or small-scale equestrian businesses.

Equine healthcare is further complicated by the need for ongoing treatments. Chronic conditions such as musculoskeletal disorders, respiratory issues, and metabolic diseases require long-term management, which leads to continuous financial burdens. Advanced treatments like stem cell therapy, laser therapy, and MRI scans can be prohibitively expensive, limiting access to necessary medical interventions. Insurance coverage for equine healthcare is not as widely available or comprehensive as human health insurance, making it difficult for owners to afford specialized care without significant out-of-pocket expenses.

The rising cost of equine healthcare has also impacted equestrian sports and breeding programs. Competitive horses require top-tier medical care to maintain performance and prevent injuries. When specialized care becomes unaffordable, it leads to compromised treatment quality, potential neglect, or premature retirement of horses from competitions. In breeding programs, high veterinary costs affect reproductive health management, including artificial insemination and embryo transfer services. Without affordable specialized care, the long-term sustainability of horse ownership and equine-related industries remains a challenge. Addressing these cost concerns through innovative financing options, insurance expansion, and technological advancements in affordable treatments is crucial for supporting the growth of the equine healthcare market.

Key Market Trends

Precision Medicine and Personalized Care

The global equine healthcare market is witnessing a shift toward precision medicine and personalized care, driven by advancements in veterinary diagnostics, genomics, and data-driven treatment approaches. Precision medicine focuses on tailoring healthcare solutions based on the specific genetic, physiological, and environmental factors of each horse. Veterinarians are leveraging genomic testing and biomarker analysis to develop individualized treatment plans, ensuring more effective disease management and preventive care. Genetic profiling enables early detection of predispositions to conditions such as laminitis, musculoskeletal disorders, and respiratory diseases, allowing for targeted interventions before clinical symptoms emerge. Personalized nutrition plans, based on metabolic profiling, are helping optimize horse health, performance, and longevity.

Wearable health-monitoring devices and telemedicine solutions are enhancing personalized care by continuously tracking vital parameters, including heart rate, temperature, and gait patterns. These real-time insights allow early detection of health abnormalities, reducing the risk of severe illnesses and costly medical interventions. Equine athletes benefit from customized rehabilitation programs, integrating physiotherapy, regenerative medicine, and laser therapy tailored to their specific recovery needs. The adoption of stem cell and gene therapy is further revolutionizing treatment strategies by offering regenerative solutions customized to the genetic makeup and condition of individual horses.

Key Market Players

Zoetis Inc.
Boehringer Ingelheim GmbH
Merck & Co., Inc.
Hallmarq Veterinary Imaging Ltd
Esaote SpA
Vetoquinol SA
IDEXX Laboratories, Inc.
Dechra Pharmaceuticals PLC
Arthrex Inc.
Heska Corporation

Report Scope:

In this report, the Global Equine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Healthcare Market, By Product:

Vaccines
Pharmaceuticals
Medicinal Feed Additives
Diagnostics
Software & Services
Others

Equine Healthcare Market, By Indication:

Musculoskeletal Disorders
Parasite Control
Internal Medicine
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
Others

Equine Healthcare Market, By Activity:

Sports/Racing
Recreation
Others

Equine Healthcare Market, By Distribution Channel:

Veterinary Hospitals & Clinics
E-commerce
Others

Equine Healthcare Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Healthcare Market.

Available Customizations:

Global Equine Healthcare market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Equine Healthcare Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
- 5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
- 5.2.3. By Activity (Sports/Racing, Recreation, Others)
- 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
- 5.2.5. By Company (2024)
- 5.2.6. By Region
5.3. Market Map

6. North America Equine Healthcare Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Indication
- 6.2.3. By Activity
- 6.2.4. By Distribution Channel
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Equine Healthcare Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Indication
    - 6.3.1.2.3. By Activity
    - 6.3.1.2.4. By Distribution Channel
- 6.3.2. Mexico Equine Healthcare Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Indication
    - 6.3.2.2.3. By Activity
    - 6.3.2.2.4. By Distribution Channel
- 6.3.3. Canada Equine Healthcare Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Indication
    - 6.3.3.2.3. By Activity
    - 6.3.3.2.4. By Distribution Channel

7. Europe Equine Healthcare Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Indication
- 7.2.3. By Activity
- 7.2.4. By Distribution Channel
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Equine Healthcare Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Indication
    - 7.3.1.2.3. By Activity
    - 7.3.1.2.4. By Distribution Channel
- 7.3.2. Germany Equine Healthcare Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Indication
    - 7.3.2.2.3. By Activity
    - 7.3.2.2.4. By Distribution Channel
- 7.3.3. United Kingdom Equine Healthcare Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Indication
    - 7.3.3.2.3. By Activity
    - 7.3.3.2.4. By Distribution Channel
- 7.3.4. Italy Equine Healthcare Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Indication
    - 7.3.4.2.3. By Activity
    - 7.3.4.2.4. By Distribution Channel
- 7.3.5. Spain Equine Healthcare Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Indication
    - 7.3.5.2.3. By Activity
    - 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Equine Healthcare Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Indication
- 8.2.3. By Activity
- 8.2.4. By Distribution Channel
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Equine Healthcare Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Indication
    - 8.3.1.2.3. By Activity
    - 8.3.1.2.4. By Distribution Channel
- 8.3.2. India Equine Healthcare Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Indication
    - 8.3.2.2.3. By Activity
    - 8.3.2.2.4. By Distribution Channel
- 8.3.3. South Korea Equine Healthcare Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Indication
    - 8.3.3.2.3. By Activity
    - 8.3.3.2.4. By Distribution Channel
- 8.3.4. Japan Equine Healthcare Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Indication
    - 8.3.4.2.3. By Activity
    - 8.3.4.2.4. By Distribution Channel
- 8.3.5. Australia Equine Healthcare Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Indication
    - 8.3.5.2.3. By Activity
    - 8.3.5.2.4. By Distribution Channel

9. South America Equine Healthcare Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Indication
- 9.2.3. By Activity
- 9.2.4. By Distribution Channel
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Equine Healthcare Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Indication
    - 9.3.1.2.3. By Activity
    - 9.3.1.2.4. By Distribution Channel
- 9.3.2. Argentina Equine Healthcare Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Indication
    - 9.3.2.2.3. By Activity
    - 9.3.2.2.4. By Distribution Channel
- 9.3.3. Colombia Equine Healthcare Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Indication
    - 9.3.3.2.3. By Activity
    - 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Equine Healthcare Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Indication
- 10.2.3. By Activity
- 10.2.4. By Distribution Channel
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Equine Healthcare Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Indication
    - 10.3.1.2.3. By Activity
    - 10.3.1.2.4. By Distribution Channel
- 10.3.2. Saudi Arabia Equine Healthcare Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Indication
    - 10.3.2.2.3. By Activity
    - 10.3.2.2.4. By Distribution Channel
- 10.3.3. UAE Equine Healthcare Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Indication
    - 10.3.3.2.3. By Activity
    - 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Zoetis Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Boehringer Ingelheim GmbH
14.3. Merck & Co., Inc.
14.4. Hallmarq Veterinary Imaging Ltd
14.5. Esaote SpA
14.6. Vetoquinol SA
14.7. IDEXX Laboratories, Inc.
14.8. Dechra Pharmaceuticals PLC
14.9. Arthrex Inc.
14.10. Heska Corporation